Hematological Malignancies
📧 Sign up to get email alerts when something new happens for Hematological Malignancies.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-22Clinical Trial Results: Expanded Access of Omidubicel, for Allogeneic Transplantation in Patients With Hematological Malignancies [Phase 3]
Phase 3 expanded access trial results for omidubicel in allogeneic transplantation for hematological malignancies have been completed with p…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Kinectics of Donor-specific Anti-HLA Antibody After HLA-incompatible Allogeneic Haematopoietic Stem Cell Transplantation
This clinical trial update examines the kinetics of donor-specific anti-HLA antibodies after HLA-incompatible allogeneic hematopoietic stem …
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Research Study of Bone Marrow Transplantation From Unrelated or Partially Matched Related Donors [Phase 2]
Phase 2 trial update on allogeneic hematopoietic stem cell transplantation from unrelated or partially matched related donors for hematologi…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Hepatosplenic CANdidiasis : PETscan and Immune Response Analysis [NA]
A completed clinical trial evaluating hepatosplenic candidiasis using PET scans and immune response analysis in patients with invasive candi…
-
CLINICAL_TRIALS trial_result · 2025-05-16Clinical Trial Update: Safety, Tolerability and Pharmacokinetics Study of KPG-818 in Hematological Malignancies Subjects [Phase 1]
A completed Phase 1 study assessing safety, tolerability and pharmacokinetics of KPG-818 in patients with hematological malignancies.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-07-18Clinical Trial Update: A Study of ATG-018 (ATR Inhibitor) Treatment in Patients With Advanced Solid Tumors and Hematological Malignancies [Phase 1]
Phase 1 study of ATG-018, an ATR inhibitor, in patients with advanced solid tumors and hematological malignancies has been terminated.
-
CLINICAL_TRIALS trial_result · 2023-12-18Clinical Trial Update: Allogeneic Immunotherapy for Hematological Malignancies by Selective Depletion of Regulatory T Cells [Phase 3]
Phase 3 trial update on allogeneic immunotherapy for hematological malignancies focusing on selective depletion of regulatory T cells.
-
CLINICAL_TRIALS trial_result · 2023-11-03Clinical Trial Update: Dose-range Finding Treosulfan-based Conditioning [Phase 1, Phase 2]
A dose-range finding study of treosulfan-based conditioning for hematological malignancies completed Phase 1/2.
-
CLINICAL_TRIALS trial_result · 2022-12-21Clinical Trial Update: CMV Specific T Cell Therapy After Allogeneic Stem Cell Transplantation. [Phase 2]
Phase 2 trial evaluating CMV-specific T cell therapy after allogeneic stem cell transplantation in hematologic malignancies with CMV infecti…
-
CLINICAL_TRIALS trial_result · 2022-11-10Clinical Trial Update: Switched Memory B-cells as a Marker for Humoral Immune System Recovery in Patients With Secondary Antibody Deficiency Due to Hematological Malignancies [Phase 4]
Phase 4 trial investigating switched memory B-cells as a marker for humoral immune system recovery in patients with secondary antibody defic…
-
CLINICAL_TRIALS trial_result · 2022-07-21Clinical Trial Update: Infusion of Depleted T Cells Following Unrelated Donor Stem Cell Transplant (ICAT) [Phase 1, Phase 2]
Phase 1/2 trial assessing infusion of depleted T cells after unrelated donor stem cell transplant for hematological malignancies has complet…
-
CLINICAL_TRIALS trial_result · 2022-07-19Clinical Trial Update: PRevention Of BLeeding in hEmatological Malignancies With Antifibrinolytic (Epsilon Aminocaproic Acid) [Phase 2]
Phase 2 trial evaluating epsilon-aminocaproic acid to prevent bleeding in patients with hematological malignancies and thrombocytopenia; stu…
-
CLINICAL_TRIALS trial_result · 2022-01-26Clinical Trial Update: Allogeneic HCT With HLA-matched Donors : a Phase II Randomized Study Comparing 2 Nonmyeloablative Conditionings [Phase 2]
Phase II randomized trial comparing two nonmyeloablative conditioning regimens for allogeneic hematopoietic cell transplantation from HLA-ma…
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: MiHA-loaded PD-L-silenced DC Vaccination After Allogeneic SCT [Phase 1, Phase 2]
Phase 1/2 trial evaluating MiHA-loaded PD-L-silenced dendritic cell vaccination after allogeneic stem cell transplantation in hematological …
-
CLINICAL_TRIALS trial_result · 2021-04-01Clinical Trial Update: Safety Study of the Selective Inhibitor of Nuclear Export (SINE) KPT-330 in Patients With Advanced Hematological Cancer [Phase 1]
Phase 1 safety study of KPT-330 (selective inhibitor of nuclear export) in advanced hematological cancers completed; results available.
-
CLINICAL_TRIALS trial_result · 2021-03-19Clinical Trial Update: Intrabone Infusion of Cord Blood in Adults With Hematological Malignancies [Phase 2]
Phase 2 clinical trial update evaluating intrabone infusion of cord blood in adults with hematological malignancies has completed.
-
CLINICAL_TRIALS trial_result · 2021-03-10Clinical Trial Update: Sequential Radiotherapy With CAR-T Cells in the Treatment of Relapsed and Refractory Hematological Malignancies With Extramedullary Lesions [Phase 1, Phase 2]
Phase 1/2 trial evaluating sequential radiotherapy combined with CAR-T cells for relapsed/refractory hematological malignancies with extrame…
-
CLINICAL_TRIALS trial_result · 2020-09-21Clinical Trial Update: Transplantation of NiCord®, Umbilical Cord Blood-derived Ex Vivo Expanded Cells, in Patients With HM [Phase 1, Phase 2]
Phase 1/2 clinical trial update for NiCord (umbilical cord blood-derived ex vivo expanded cells) in hematological malignancies, including AL…
-
CLINICAL_TRIALS trial_result · 2020-03-11Clinical Trial Update: Pasireotide in Prevention of GI Toxicity [Phase 2]
Phase 2 clinical trial evaluating pasireotide for prevention of GI toxicity in hematological malignancies has completed with posted results …
-
CLINICAL_TRIALS trial_result · 2020-01-07Clinical Trial Update: Zinc as Enhancer in Immune Recovery After Stem Cell Transplantation for Hematological Malignancies [Phase 2]
Phase 2 trial update exploring zinc as an enhancer of immune recovery after stem cell transplantation for hematological malignancies.
-
CLINICAL_TRIALS trial_result · 2019-11-26Clinical Trial Update: Prevention of Acute Graft Versus Host Disease in Patients Undergoing Allogeneic ApoGraft Stem Cell Transplantation [Phase 1, Phase 2]
Clinical trial update on prevention of acute graft-versus-host disease in patients receiving allogeneic ApoGraft stem cell transplantation (…
-
CLINICAL_TRIALS trial_result · 2018-11-07Clinical Trial Update: Antibacterial Prophylaxis vs no Prophylaxis for Hematological Malignancies Patients Before Allo-HSCT [Phase 2, Phase 3]
A phase 2/3 clinical trial evaluating antibacterial prophylaxis versus no prophylaxis in hematological malignancy patients prior to allogene…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Prevention of Osteoporosis in Bone Marrow Transplantation (BMT) Patients [Phase 3]
Phase 3 trial assessing prevention of osteoporosis in bone marrow transplantation patients; completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2017-06-01Clinical Trial Update: Tacrolimus and Thymoglobulin, as GvHD Prophylaxis in Patients Undergoing Related Donor HCT [Phase 2]
Phase 2 trial evaluating tacrolimus and thymoglobulin as graft-versus-host disease prophylaxis in related donor hematopoietic cell transplan…
-
CLINICAL_TRIALS trial_result · 2016-03-10Clinical Trial Update: Allogeneic Hematopoietic Stem Cell Transplantation With Reduced Intensity Pre-transplant Conditioning for the Treatment of High-risk Hematological Malignancies (V3) [Phase 2]
A Phase 2 study investigating reduced-intensity pre-transplant conditioning prior to allogeneic hematopoietic stem cell transplantation for …